Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 5:25 pm Purchase | 2021-02-05 | 13D | Gemini Therapeutics, Inc. GMTX | Atlas Venture Fund X L.P. | 401,505 8.900% | 401,505 (New Position) | Filing History |
| 2020-09-17 4:50 pm Sale | 2020-09-15 | 13D | Replimune Group, Inc. REPL | Atlas Venture Fund X L.P. | 2,524,866 6.300% | -436,607 (-14.74%) | Filing History |
| 2020-07-14 4:34 pm Unchanged | 2020-06-29 | 13D | Magenta Therapeutics, Inc. MGTA | Atlas Venture Fund X L.P. | 4,117,125 8.700% | 0 (Unchanged) | Filing History |
| 2020-07-07 5:11 pm Sale | 2020-07-02 | 13D | Replimune Group, Inc. REPL | Atlas Venture Fund X L.P. | 2,961,473 7.500% | -436,607 (-12.85%) | Filing History |
| 2020-06-19 5:03 pm Sale | 2020-06-16 | 13D | Replimune Group, Inc. REPL | Atlas Venture Fund X L.P. | 3,398,080 8.600% | -436,507 (-11.38%) | Filing History |